Reported 19 days ago
Pfizer Inc. (NYSE:PFE) is recognized as one of the top dividend stocks, boasting a yield of 6.94% as of October 12. Despite facing recent declines in revenue and market value, Pfizer is actively working to turn things around, including a $5 billion acquisition of biotech firm Metsera to expand into the weight management market. The company's strong oncology pipeline and its history of 15 consecutive years of dividend increases make it an attractive option for income-focused investors.
Source: YAHOO